United States · FDA National Drug Code directory
Theophylline
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-722_588a56f6-ac5a-415e-99ac-fdb836e0202f
- Product NDC
- 68462-722
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Theophylline
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210603
- Source listing expiry
- 20271231
Source-listed ingredients
- THEOPHYLLINE ANHYDROUS — 450 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-722-01) · 68462-722-01
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-722-05) · 68462-722-05
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-722-30) · 68462-722-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →